Grimaldi’s shareholders’ meeting approves a €50 million capital increase in Trasmed to strengthen its balance sheet

The Grimaldi Group has decided to carry out a new capital increase of €50 million in its Spanish subsidiary Trasmed. The decision, made by the shareholders of the shipping company, aims to strengthen the company’s financial position and reduce its debt burden. With this operation, Trasmed’s share capital now stands at €347 million.

The company, which operates ferry services between mainland Spain and the Balearic Islands, was established in 2021 following the acquisition of assets from the Armas Trasmediterránea group. This capital injection from the parent company will be specifically used to reduce accumulated debt, mainly stemming from the syndicated loan signed to finance the initial acquisition of the vessels that make up its assets. Once the capital increase is completed, Trasmed’s total debt will be reduced to €26.4 million.

The Grimaldi Group closed the 2024 financial year with more than €1.4 billion in cash and a turnover exceeding €5 billion.

Maritime artificial intelligence Go deeper with:

Sign up free to ask CAMAL AI for a summary, the key points or anything else about this story.

Sign up free I already have an account

Related stories

CAMAL AI

DP World Revenue Rises 13.1% to $12.7 Billion as Global Portfolio Navigates Trade Disruption FP Panama Strengthens Internatioal Confidence in its Ship Registry whith ISO 9001:2015 recertification FP bound4blue completes eSAIL® installation on groundbreaking South Pacific multipurpose vessel FP